CombiMatrix's Q1 Revenues Drop 13 Percent as Firm Focuses on Dx Business

Though its overall revenues declined, CombiMatrix's diagnostics lab business, which will be its focus following its current restructuring, reported 13 percent revenue growth.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.